TABLE 1.
Bacterial strains used in this study
| Strain | Relevant characteristic(s) | Reference or source |
|---|---|---|
| CIP 70-10 | Susceptible reference strain | 3 |
| BM4546 | CIP 70-10 AdeST153M spontaneous mutant, MDR | 25 |
| BM4547 | CIP 70-10 AdeRP116L spontaneous mutant, MDR | 25 |
| BM4454 | Clinical strain overexpressing AdeABC | 24 |
| BM4579 | BM4454 ΔadeIJK | 9 |
| BM4651 | BM4454 ΔadeABC | 9 |
| BM4652 | BM4454 ΔadeABC ΔadeIJK | 9 |
| BM4587 | Susceptible clinical strain | This study |
| BM4665 | BM4587 spontaneous mutant obtained on gentamicin, MDR | This study |
| BM4666 | BM4587 spontaneous mutant obtained on cefotaxime, MDR | This study |
| BM4667 | Susceptible clinical strain | This study |
| BM4668 | BM4667 spontaneous mutant obtained on tetracycline, MDR | This study |
| AYE | MDR clinical strain | 16 |
| BM4675 | MDR clinical strain | This study |
| BM4676 | MDR clinical strain | This study |